Compare AdaptHealth Corp (AHCO) vs Meta Platforms Inc (META) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

META trades at $605.36, up 0.84% with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 2025 revenue of $201B, net income margin of 32.84%, and improving cash flow trends. Recent AI developments including the Muse Spark launch and positive analyst sentiment support growth prospects despite legal challenges.

META presents a compelling investment case with strong profitability, AI innovation leadership, and analyst consensus pointing to significant upside. Key risks include regulatory lawsuits and high capital expenditures, but the company's financial strength and market position suggest continued growth potential for long-term investors.